Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis-Reference-Cited by-同舟云学术

Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis

Published:2023-10 Issue:10 Volume:35 Page:1752-1766.e8
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Kuang Junliang,Wang Jieyi,Li Yitao,Li Mengci,Zhao Mingliang,Ge Kun,Zheng Dan,Cheung Kenneth C.P.,Liao Boya,Wang Shouli,Chen Tianlu,Zhang Yinan,Wang Congrong,Ji Guang,Chen Peng,Zhou Hongwei,Xie Cen,Zhao Aihua,Jia Weiping,Zheng Xiaojiao,Jia Wei^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference50 articles.

1. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement;Eslam;J. Hepatol.,2020

2. Global multi-stakeholder endorsement of the MAFLD definition;Méndez-Sánchez;Lancet Gastroenterol. Hepatol.,2022

3. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults;Liu;Clin. Gastroenterol. Hepatol.,2022

4. A global view of the interplay between non-alcoholic fatty liver disease and diabetes;Stefan;Lancet Diabetes Endocrinol.,2022

5. Non-alcoholic fatty liver disease;Powell;Lancet,2021

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiota and its metabolites: A potential approach for traditional Chinese medicine-derived non-starch polysaccharides to delay aging and prevent age-related diseases–A review;Carbohydrate Polymer Technologies and Applications;2024-12

2. Perfluorooctanoic acid (PFOA) and its alternative perfluorobutanoic acid (PFBA) alter hepatic bile acid profiles via different pathways;Science of The Total Environment;2024-11

3. The mechanistic study of diacylglycerol in ameliorating non-alcoholic fatty liver and systemic lipid accumulation;Journal of Functional Foods;2024-10

4. Unveiling the microbial metabolites in ruminant milk for medicinal purposes;Food Frontiers;2024-09-04

5. Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress;Chemico-Biological Interactions;2024-09